Maria Elisa Mancuso - Concepedia

Author

Maria Elisa Mancuso

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico ORCID

Also Known As

A.R. Cid, E. MANCUSO, Elena Santagostino, Kasthuri, Raj, M Biss, M E Mancuso, M Elisa Mancuso, M MANCUSO, M Mancuso, M. E. MANCUSO

288

Publications

7.6K

Citations

H-Index

108

Concepts

All Affiliations

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico University of Milan Ospedale Maggiore IRCCS Humanitas Research Hospital University of the Witwatersrand

About

Maria Elisa Mancuso is an author at Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	29	1.5K
2	Health Sciences	9	9	636
3	Public Health	7	7	330
4	Arts	1	1	28
5	Nursing	1	1	28

Maria Elisa Mancuso

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors Johnny Mahlangu, Johannes Oldenburg, Ido Paz‐Priel, New England Journal of Medicine	2018	708
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A Flora Peyvandi, Pier Mannuccio Mannucci, Isabella Garagiola, New England Journal of Medicine	2016	483
A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors Guy Young, Ri Liesner, Tiffany Chang, Blood	2019	361
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study Samantha C. Gouw, H. Marijke van den Berg, Kathelijn Fischer, Blood	2013	319
Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies Michael U. Callaghan, Claude Négrier, Ido Paz‐Priel, Blood ThrombosisAntibioticsPediatric HematologyBleed RateHematology	2020	270
Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile Elena Santagostino, Maria Elisa Mancuso, Armando Tripodi, Journal of Thrombosis and Haemostasis ThrombosisMolecular CharacterizationHematologyImmunologyPathology	2010	206
Environmental risk factors for inhibitor development in children with haemophilia A: a case–control study Elena Santagostino, Maria Elisa Mancuso, Angiola Rocino, British Journal of Haematology	2005	192
Mortality and causes of death in Italian persons with haemophilia, 1990–2007 Annarita Tagliaferri, G Rivolta, Alfonso Iorio, Haemophilia Epidemiological TrendDeath RateItalian PersonsEpidemiological OutcomeGlobal Health	2010	168
A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors Elena Santagostino, Maria Elisa Mancuso, Angiola Rocino, Journal of Thrombosis and Haemostasis Standard DosagesPharmacologyHematologyRecombinant Factor ViiaHemostasis	2006	164
Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study G. Peter Feola, Angelo Claudio Molinari, Cristina Santoro, Thrombosis and Haemostasis	2015	113

Page 1